Home / Agencies / EPA / 2026-10709
Final Rule

Bacillus Thuringiensis Cry1B.34.1, Bacillus Thuringiensis Cry1B.61.1 and Adiantum Trapeziforme var. Braziliense IPD083Cb Proteins; Pesticide Tolerances

Agency
Document Number
2026-10709
Published
May 29, 2026
Effective Date
May 29, 2026

Abstract

This regulation establishes exemptions from the requirement of a tolerance for residues of the Bacillus thuringiensis Cry1B.34.1, Bacillus thuringiensis Cry1B.61.1, and Adiantum trapeziforme var. braziliense IPD083Cb proteins (hereafter Cry1B.34.1, Cry1B.61, and IPD083Cb proteins) in or on all food and feed commodities when used as plant-incorporated protectants (PIP). Pioneer Hi-Bred International Inc. (Pioneer) submitted a petition to EPA under the Federal Food, Drug, and Cosmetic Act (FFDCA), requesting exemptions from the requirement of a tolerance. This regulation eliminates the need to establish maximum permissible levels for residues of Cry1B.34.1, Cry1B.61, and IPD083Cb proteins when used in accordance with the terms of the exemption.

Federal Register Source

This document is published by the Office of the Federal Register, National Archives and Records Administration. Access the full regulatory text, preamble, and docket comments below.

View Full Text on FederalRegister.gov →

Opens in new tab · federalregister.gov

Frequently Asked Questions

What is the 2026-10709 Federal Register document?
Document 2026-10709 is a Final Rule published by the Environmental Protection Agency in the Federal Register on May 29, 2026, with an effective date of May 29, 2026. This regulation establishes exemptions from the requirement of a tolerance for residues of the Bacillus thuringiensis Cry1B.34.1, Bacillus thuringiensis Cry1B.61.1, and Adiantum trapeziforme var. braziliense IPD083Cb proteins (hereafter Cry1B.34.1, Cry1B.61, and IPD083Cb proteins) in or on all food and feed commodities when used as plant-incorporated protectants (PIP). Pioneer Hi-Bred International Inc. (Pioneer) submitted a petition to EPA under the Federal Food, Drug, and Cosmetic Act (FFDCA), requesting exemptions from the requirement of a tolerance. This regulation eliminates the need to establish maximum permissible levels for residues of Cry1B.34.1, Cry1B.61, and IPD083Cb proteins when used in accordance with the terms of the exemption. View the original at https://www.federalregister.gov/documents/2026/05/29/2026-10709/bacillus-thuringiensis-cry1b341-bacillus-thuringiensis-cry1b611-and-adiantum-trapeziforme-var.
Is document 2026-10709 an economically significant rule?
No. Document 2026-10709 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.
Data sourced from official state legislatures, IAPP, NCSL, and federal regulatory trackers. See our methodology for details. Retrieved and formatted by PlainRegWatch Editorial

Every figure on PlainRegWatch is rendered directly from state source data, no number is typed in by an editor. This page draws directly on federal and state source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.